Health technology assessments and pharmaceutical pricing

By Dr Wolfgang A Rehmann and Diana Heimhalt

Pharmaceutical benefit assessments play an increasingly important role in refunds by the national health services. In most European countries, a drug has to successfully pass a post-approval benefit evaluation before it becomes available in the publicly funded healthcare system. Most European member states have implemented health technology assessments-based pharmaceutical evaluation schemes; their results form the basis for pharmaceutical pricing.

The EU member states maintain different pricing systems. There are basically two variations…

If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer


5 New Street Square

Turnover (£m): 228.00
No. of lawyers: 860
Jurisdiction: UK
No. of offices: 4
No. of qualified lawyers: 67 (International 50)